1. Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific 89Zr-Labeled Natalizumab Immuno-Positron Emission Tomography
   Mina Kim et al, 2024, Molecular Pharmaceutics CrossRef
2. Targeting integrins in drug‐resistant acute myeloid leukaemia
   Heather A. Ogana et al, 2024, British Journal of Pharmacology CrossRef
3. Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide
   Zachary D. Crees et al, 2023, Therapeutic Advances in Hematology CrossRef
4. Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance
   Katerina E. Miari et al, 2024, British Journal of Pharmacology CrossRef
5. Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics
   Nathaly Poveda-Garavito et al, 2024, Frontiers in Immunology CrossRef
6. Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook
   Yongsheng Ruan et al, 2022, Frontiers in Endocrinology CrossRef
7. Applying Rituximab During the Conditioning Regimen Prevents Epstein–Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplant in a Children’s Cohort: A Retrospective Case–Control Study
   Yongsheng Ruan et al, 2023, Infectious Diseases and Therapy CrossRef